Breakthrough Chemistry, Inc.
BKTH
Get informed when a big investor buys or sells
+ FollowMarket Cap$690.78K
Close$
$-0.00
101% downside
Current Fair Value
101% downsideOvervalued by 101% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $690,781.00 |
|---|---|
| Enterprise Value | $1.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.15 |
| Beta | 4.77 |
| Outstanding Shares | 9,729,304 |
Return
| Return on Equity | -54.05% |
|---|---|
| Return on Assets | -26.73% |
| Return on Invested Capital | -47.93% |
Valuation & Multiples
| P/E Ratio | 2.63 |
|---|---|
| PEG | 0.66 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 54.94 |
| Enterprise Value to EBIT | -4.81 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Breakthrough Chemistry, Inc.
3 employees
CEO: Robert Gardiner Breakthrough Chemistry, Inc. is an innovator in the chemical sector, engineering novel compounds and formulations that challenge established industry standards. Leveraging its advanced chemistry platform, the company provides critical so...